42

BrainStorm

June 20, 2023

John Dwyer: The Latest Battle on Medicare Reimbursement for Alzheimer’s Drugs

John Dwyer: The Latest Battle on Medicare Reimbursement for Alzheimer’s Drugs

About This Episode

Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke with host Meryl Comer about the ramification to patients and how this decision will create greater disparities. Take a listen.

This episode is sponsored by Genentech and Eisai. 

Support the show

BrainStorm Feed

100
December 16, 2025 | 22:29

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99
December 2, 2025 | 16:32

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98
November 18, 2025 | 16:52

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW